phenylacetylglutamine has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Ma, X; Qiu, L; Tang, Y; Yu, S; Zhang, L; Zou, Y | 1 |
| Cajka, T; DiDonato, JA; Fiehn, O; Fischbach, MA; Funabashi, M; Gupta, N; Hazen, SL; Li, L; Mohan, ML; Naga Prasad, SV; Nemet, I; Ramer-Tait, AE; Rey, FE; Romano, KA; Saha, PP; Skye, SM; Tang, WHW; Wu, Y; Zhu, W | 1 |
2 other study(ies) available for phenylacetylglutamine and Cardiovascular Stroke
| Article | Year |
|---|---|
Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2DM and AMI using a liquid chromatography tandem mass spectrometry method.
Topics: Chromatography, Liquid; Diabetes Mellitus, Type 2; Glutamine; Humans; Isotopes; Methylamines; Myocardial Infarction; Tandem Mass Spectrometry | 2022 |
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors.
Topics: Animals; Arteries; Bacterial Proteins; Blood Platelets; Cardiovascular Diseases; Death, Sudden, Cardiac; Gastrointestinal Microbiome; Glutamine; Humans; Male; Metabolome; Metabolomics; Mice; Myocardial Infarction; Platelet Activation; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Risk Factors; Stroke; Thrombosis | 2020 |